Osanni Bio

Scaled Innovation of Transformative Medicines

San Francisco, United States · Founded 2023 · $230.0M raised

Employees
11–50
Founded
2023
Business Model
B2B
Website
osanni.bio
Total Funding
$230.0M
Last Round
$190.0M Venture RoundJun 2026
Rounds
2

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 2 funding rounds and 2 investors for this company. The full record is or through the API.

About

Osanni Bio is a San Francisco-based development-stage therapeutics company that applies a biodesign-driven innovation engine to discover and develop novel therapies in ophthalmology and cardiology. The company's model centers on building specialized affiliate spinoff companies around validated drug targets, funded with $190 million in Series B financing led by Patient Square Capital.

Summary

Osanni Bio is a Biotech company based in San Francisco, United States, founded in 2023. It has raised $230.0M in total across 2 rounds, most recently a $190.0M Venture Round in Jun 2026. Investors include Horowitz Group and Invus.

Tech & App Stack

1 technology or app tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Venture RoundVenture RoundJun 2026
$190.0M

Sign up to see all 2 events

Funding: Venture Round. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Osanni Bio on Indexed.vc
<a href="https://indexed.vc/companies/osanni-bio"><img src="https://indexed.vc/api/badge/company/osanni-bio" alt="Osanni Bio on Indexed.vc" width="260" height="76" /></a>